Methods: This 3-month study was a pilot randomized controlled trial of 30 patients with T2D followed at a university-affiliated Family Medicine Group. The aims of this study were: (I) to evaluate the impact of an activity tracker on PA and cardiometabolic risk variables in patients with T2D (II) to assess the feasibility of its implantation in a primary care setting. The use of an activity tracker to monitor physical activity (PA) could favor behavior changes in patients with chronic diseases such as diabetes. ^ORCID: Cynthia Pelletier, 0000-0003-1573-0519 Caroline Rhéaume, 0000-0002-1863-4410.īackground: Adopting healthy lifestyle habits reduces the risk of type 2 diabetes (T2D) and its complications.
Cynthia Pelletier 1,2^, Marie-Pierre Gagnon 2,3, Natalie Alméras 4,5, Jean-Pierre Després 2,4,5, Paul Poirier 4,6, Angelo Tremblay 2,4,5, Christian Chabot 2, Caroline Rhéaume 1,2,4^ġ Department of Family Medicine and Emergency Medicine, Faculty of Medicine, Université Laval, Québec, Canada Ģ VITAM - Centre de recherche en santé durable, CIUSSS-Capitale-Nationale, Université Laval, Québec, Canada ģ Faculty of Nursing, Université Laval, Québec, Canada Ĥ Centre de recherche de l’Institut universitaire de cardiologie et de pneumologie de Québec, Québec, Canada ĥ Department of Kinesiology, Faculty of Medicine, Université Laval, Québec, Canada Ħ Faculty of Pharmacy, Université Laval, Québec, CanadaĬontributions: (I) Conception and design: MP Gagnon, C Chabot, C Rhéaume (II) Administrative support: MP Gagnon, C Rhéaume, C Chabot, N Alméras (III) Provision of study materials or patients: MP Gagnon, C Rhéaume (IV) Collection and assembly of data: C Pelletier, MP Gagnon, C Rhéaume (V) Data analysis and interpretation: C Pelletier, MP Gagnon, C Rhéaume (VI) Manuscript writing: All authors (VII) Final approval of manuscript: All authors.
0 kommentar(er)
